🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Anapharm Inc.
Start Date
2002-01
Trial ID
NCT00835263
Treatments Being Tested
This clinical study compares the effectiveness of two anticonvulsants Lamot...
Status
Completed
Location
National Institute of Mental Health (NIMH)
Start Date
1995-05
Trial ID
NCT00001482
Treatments Being Tested
Management of excessive crying in children with cerebral palsy and communic...
Status
Completed
Location
Multiple Locations
Start Date
2005-12-07
Trial ID
NCT04523935
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Anapharm Inc.
Start Date
2002-02
Trial ID
NCT00838279
Treatments Being Tested
* Objective: * A randomized, open label, two treatment, two period, two ...
Status
Completed
Location
Lotus Labs Pvt. Ltd.
Start Date
TBD
Trial ID
NCT00939614
Treatments Being Tested
This is an single dose,two-way, crossover, oral bioequivalence study....
Status
Completed
Location
AAI Clinic
Start Date
2002-12
Trial ID
NCT01513720
Treatments Being Tested
The main purpose of this study is to examine the effect of multiple doses o...
Status
Completed
Location
Celerion, Inc
Start Date
2019-07-15
Trial ID
NCT04015687
Treatments Being Tested
* Objective: * To assess the bioequivalence of Lamotrigine 2 x 25 mg IR ...
Status
Completed
Location
Lotus Labs Pvt. Ltd.
Start Date
TBD
Trial ID
NCT00939458
Treatments Being Tested
This is an open Label, randomized, two-period, two-treatment, two-sequence,...
Status
Completed
Location
Cliantha Research Limited
Start Date
2012-03
Trial ID
NCT01618825
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2004-08
Trial ID
NCT00647751
Treatments Being Tested